Last updated on June 2017

Low to Intermediate-Risk Prostate Cancer


Brief description of study

Low to Intermediate-Risk Prostate Cancer

Detailed Study Description

A Multi-Center, Open Label, Phase 2b study, Evaluating the safety, tolerability and efficacy of Targeted Intraprostatic Administration of XXXXX to treat men with histologically proven, clinically significant, localized, Low-to Intermediate-Risk Prostate Cancer that is associated with an MRI Leasion

Clinical Study Identifier: TX150683

Contact Investigators or Research Sites near you

Start Over

Cheryl Ahlstrom

South Florida Medical Research
Aventura, FL USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.